抗凝剂治疗中的药物相互作用:专注于瘤学患者
Kristina Vrotniakaite-Bajerciene1,2, Corey Tsang3,4, Tzu-Fei Wang1
1Department of Medicine, University of Ottawa at the Ottawa Hospital and the Ottawa Hospital Research Institute, Ottawa, Canada.
Expert review of clinical pharmacology
|November 3, 2025
概括
服用抗凝药的癌症患者面临着高的药物相互作用 (DDI) 风险. 本综述详细介绍了抗凝血剂和抗癌DDI,并提出了用于改善患者护理的实际DDI评估方法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 癌症患者通常需要抗凝剂,因为高血栓形成和心房动的风险.
- 在癌症治疗中的多药性增加了药物相互作用 (DDI) 的可能性.
- 抗凝剂具有显著的药理动力学和药理动力学DDI,其临床影响往往无法确定.
研究的目的:
- 审查抗凝剂和抗癌疗法之间的药物相互作用 (DDI).
- 在癌症患者中总结抗凝血DDI的一般原则.
- 为管理这些DDI提供一个实际的方法.
主要方法:
- 对临床前和临床研究进行了全面的文献搜索.
- 专注于DDI的药理动力学和药理动力学机制.
- 包括对死亡率,出血和血栓形成的结果研究.
主要成果:
- 详细审查各种抗凝血剂和抗癌药物类别之间的DDI.
- 对评估DDI影响的最近结果研究的分析.
- 确定关键的药理动力学和药理动力学相互作用.
结论:
- 提出了DDI评估和临床解释的实用方法.
- 建议包括系统查,量身定制的抗凝剂选择和患者咨询.
- 强调药房团队参与复杂案件的重要性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
191
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
191
Pharmacokinetics: Drug–Drug Interactions
336
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
336
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


